Education
About Us
Working with TipRanks
Follow Us
ACADIA Pharmaceuticals (ACAD)
NASDAQ:ACAD
ACADIA Pharmaceuticals (ACAD) Ownership Overview
24.05% Insiders
15.15% Mutual Funds
0.31% Other Institutional Investors
23.18% ETFs
37.31% Public Companies and
Individual Investors
The ownership structure of ACADIA Pharmaceuticals (ACAD) stock is a mix of institutional, retail, and individual investors. Approximately 38.64% of the company’s stock is owned by Institutional Investors, 24.05% is owned by Insiders, and 37.31% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Mar 06, 2025 | Elizabeth A. Garofalo Director | xxxxxxxxxxxxx | $89673 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | xxxxxxxxxxxxx | $477503 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $491137 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1133607 | |
| Dec 31, 2024 | xxxxxxxxxxxxx | $1283876 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 42,877,916 | Institution | 25.71% | 750,363,530 | |
| 39,555,503 | Insider | 23.72% | 692,221,303 | |
| 15,295,386 | Institution | 9.17% | 267,669,255 | |
| 12,497,897 | Institution | 7.49% | 218,713,198 | |
| 10,682,144 | Institution | 6.40% | 186,937,520 | |
| 3,606,571 | Institution | 2.16% | 63,114,993 | |
| 2,361,571 | Institution | 1.42% | 41,327,493 | |
| 1,892,961 | Institution | 1.13% | 33,126,818 | |
| 1,313,049 | Institution | 0.79% | 22,978,358 | |
| 1,253,708 | Institution | 0.75% | 21,939,890 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,682,144 | Institution | 6.40% | 186,937,520 | |
| 1,313,049 | Institution | 0.79% | 22,978,358 | |
| 1,253,708 | Institution | 0.75% | 21,939,890 | |
| 892,905 | Institution | 0.54% | 15,625,838 | |
| 892,845 | Institution | 0.54% | 15,624,788 | |
| 840,768 | Institution | 0.50% | 14,713,440 | |
| 789,847 | Institution | 0.47% | 13,822,323 | |
| 758,178 | Institution | 0.45% | 13,268,115 | |
| 685,699 | Institution | 0.41% | 11,999,733 | |
| 652,921 | Institution | 0.39% | 11,426,118 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,778,294 | Institution | 4.66% | 136,120,145 | |
| 3,926,432 | Institution | 2.35% | 76,958,067 | |
| 3,218,459 | Institution | 1.93% | 56,323,033 | |
| 3,177,868 | Institution | 1.91% | 58,313,878 | |
| 2,170,312 | Institution | 1.30% | 37,980,460 | |
| 1,862,323 | Institution | 1.12% | 36,501,531 | |
| 1,802,353 | Institution | 1.08% | 33,631,907 | |
| 1,569,488 | Institution | 0.94% | 26,336,009 | |
| 1,096,612 | Institution | 0.66% | 18,401,149 | |
| 1,050,010 | Institution | 0.63% | 18,375,175 |
FAQ
Who Owns ACADIA Pharmaceuticals (ACAD)?
According to the latest TipRanks data, approximately 0.31% of the company's stock is held by institutional investors, 24.05% is held by insiders, and 37.31% is held by retail investors.
What percentage of ACADIA Pharmaceuticals (ACAD) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.31% of ACADIA Pharmaceuticals (ACAD) stock is held by institutional investors.
What percentage of ACADIA Pharmaceuticals (ACAD) stock is held by retail investors?
According to the latest TipRanks data, approximately 37.31% of ACADIA Pharmaceuticals (ACAD) stock is held by retail investors.
Who owns the most shares of ACADIA Pharmaceuticals (ACAD)?
Felix Baker owns the most shares of ACADIA Pharmaceuticals (ACAD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.